CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.

Haematology
Reviewed By
Dr Robin Sanderson is a Consultant Haematologist with a specialist interest in Haemato-oncology, particularly lymphoma, chronic lymphocytic leukaemia, CAR-T cells, stem cell transplantation and therapeutic apheresis. He completed his Haematological training at Guy's and St Thomas', King's College and St Bartholomew's Hospitals in London as well as fellowships in Sydney teaching hospitals.
He completed his Haematology training in 2014 and was a Clinical Lecturer in Haemato-oncology at Barts Cancer Institute until 2019. He completed his PhD investigating CAR-T cells in chronic lymphocytic leukaemia and lymphoma and their modulation with immunotherapy in pre-clinical models at Barts. He was appointed at King's College Hospital in 2019 to lead the lymphoma CAR-T programme and has been chief/principle investigator on a number of CAR-T trials in lymphoid disorders. He is apheresis lead at King’s College Hospital for haemato-oncology.
Dr Sanderson is fully trained in the assessment and delivery of CAR-T cells, stem cell transplantation and therapeutic apheresis. Dr Sanderson has experience in rapid access diagnostic services in Haematology particular for abnormal blood counts and lymphadenopathy.
Haematological Malignancy
English
BSc MBChB MRCP FRCPath PhD
General Medical Council: 6100960
Guy's Cancer Centre, Great Maze Pond, London, SE1 9RT
40 Bank Street, London, E14 5NR
New appointment: £290
Follow-up appointment: £150
Reviewed By